Kevin Marsh

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Systematic Review

Chronic Kidney Disease

Decision Making

Transcatheter Aortic Valve Replacement

Top Venues

Future oncology (London, England)

Applied health economics and health policy

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Marsh, Hannah Collacott, Jim Thomson, Jonathan Mauer, Stephen Watt, Koonal Shah, Brett Hauber, Louis Garrison, Mendwas Dzingina
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits. The patient 17 (3) (2024)
Kevin Marsh, Hannah Collacott, Jim Thomson, Jonathan Mauer, Stephen Watt, Koonal Shah, Brett Hauber, Louis Garrison, Mendwas Dzingina
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits. The patient 17 (3) (2024)
Kevin Marsh, Hannah Collacott, Jim Thomson, Jonathan Mauer, Stephen Watt, Koonal Shah, Brett Hauber, Louis Garrison, Mendwas Dzingina
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits. The patient (2024)
Ajibade O Ashaye, Caitlin Thomas, Mehul Dalal, Vamsi Kota, Nicolas Krucien, Maria Sae-Hau, Elisa Weiss, Scott Campbell, Kevin Marsh
Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment. Future oncology (London, England) 18 (17) (2022)
Kevin Marsh, Esther Wilhelmina de Bekker-Grob, Nigel S Cook, Hannah Collacott, Andriy Danyliv
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations. International journal of technology assessment in health care 37 (1) (2021)
Kevin Marsh, Nicolas Krucien
Evaluating the Consistency of Patient Preference Estimates: Systematic Variation in Survival-Adverse Event Trade-Offs in Patients with Cancer or Cardiovascular Disease. The patient (2021)
Kevin Marsh, Kerrie-Anne Ho, Rachel Lo, Nancy Zaour, Aneesh Thomas George, Nigel S Cook
Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A Nephropathy. The patient 14 (6) (2021)
Meredith Y Smith, Janine Astrid van Til, Rachael L DiSantostefano, A Brett Hauber, Kevin Marsh
Quantitative Benefit-Risk Assessment: State of the Practice Within Industry. Therapeutic innovation & regulatory science 55 (2) (2020)
Sebastian Heidenreich, Andrea Phillips-Beyer, Bruno Flamion, Melissa Ross, Jaein Seo, Kevin Marsh
Benefit-Risk or Risk-Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment. The patient 14 (1) (2020)
Kevin Marsh, Natalia Hawken, Ella Brookes, Carrie Kuehn, Barry Liden
Patient-centered benefit-risk analysis of transcatheter aortic valve replacement. F1000Research (2019)
Kevin Marsh, Natalia Hawken, Ella Brookes, Carrie Kuehn, Barry Liden
Patient-centered benefit-risk analysis of transcatheter aortic valve replacement. F1000Research 8 (2019)
Kevin Marsh, Natalia Hawken, Ella Brookes, Carrie Kuehn, Barry Liden
Patient-centered benefit-risk analysis of transcatheter aortic valve replacement. F1000Research (2019)
Kevin Marsh, Natalia Hawken, Ella Brookes, Carrie Kuehn, Barry Liden
Patient-centered benefit-risk analysis of transcatheter aortic valve replacement. F1000Research (2019)
Kevin Marsh, J Jaime Caro, Alaa Hamed, Erica Zaiser
Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients. Applied health economics and health policy 15 (2) (2017)